Login
$KOD
$89.34 -$0.26 (0.29%) After hours

Company Executives

$KOD Management Team

Dr. Victor Perlroth

Chairman of the Board

Chief Executive Officer

Co-Founder

Age 52
Compensation $1.988M USD
Sex Male

Mr. John Borgeson

Chief Financial Officer

Executive Vice President

Secretary

Age 63
Compensation $1.356M USD
Sex Male
Directors
7
serving now
Independent
Not stated
the proxy does not say
Average tenure
9.3 years
from year joined
CEO also chairs the board
Yes
Victor Perlroth, M.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Charles A. Bancroft
66 2020
6 years
Not stated None stated GSK plc $170,300
Bassil I. Dahiyat, Ph.D.
55 2018
8 years
Not stated
Audit
Xencor, Inc. $147,800
Taiyin Yang, Ph.D.
72 2019
7 years
Not stated
Audit
Brii Biosciences Limited $147,800
Felix J. Baker, Ph.D.
57 2015
11 years
Not stated
Compensation · Chair
Kiniksa Pharmaceuticals International, plc. $92,800
Victor Perlroth, M.D.
53 2009
17 years
Not stated None stated None stated Paid as CEO
Richard S. Levy, M.D.
68 2018
8 years
Not stated
Nominating and Governance
Kiniksa Pharmaceuticals, Ltd. $142,800
Robert A. Profusek, J.D.
76 2018
8 years
Not stated
Nominating and Governance · Chair
CTS Corporation $179,300

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 22, 2026
each of our directors and certain of our officers
directors and certain officers
Amount not stated

Separate indemnification agreements entered into with each director and certain officers.

our named executive officers, other executive officers and our non-employee directors
named executive officers, other executive officers and non-employee directors
Amount not stated

Grants of stock options and RSUs to named executive officers, other executive officers and non-employee directors.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support